Concepedia
Statistics
Publications
6
Citations
210
H-Index
Active since
2013
Affiliations
The Ohio State University(Current)
Brigham and Women's Hospital
Dana-Farber Cancer Institute
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Harvard University
Tyler Haddad is an author at The Ohio State University specializing in oncology, medicine, and cancer immunotherapy.
Publications per year
2013–2022
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma
Nicole G. Chau, Yvonne Y. Li, Vickie Y. Jo et al. · Clinical Cancer Research · 2016 · 57 citations
Medicine, Molecular Genetics, Oncology +17
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
Tyler Haddad, Songzhu Zhao, Mingjia Li et al. · Cancer Immunology Immunotherapy · 2021 · 47 citations · Full text
Life Sciences, Immunology, Oncology +17
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Yizhen Guo, Lai Wei, Sandip H. Patel et al. · Clinical Lung Cancer · 2022 · 44 citations · Full text
Medicine, Pharmacology, Cancer Immunology +3
Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial
Weidong Lu, Peter M. Wayne, Roger B. Davis et al. · The Oncologist · 2016 · 26 citations · Full text
Medicine, Oncology, Otolaryngology +17
A phase II study of everolimus in patients with aggressive RAI refractory (RAIR) thyroid cancer (TC).
Jochen H. Lorch, Naifa L. Busaidy, Daniel T. Ruan et al. · Journal of Clinical Oncology · 2013 · 25 citations
Medicine, Oncology, Pharmacology +17
1–5 of 6